Literature DB >> 7675117

Investigation of the 5-hydroxytryptamine receptor mediating the "transient" short-circuit current response in guinea-pig ileal mucosa.

E Leung1, D Blissard, M F Jett, R M Eglen.   

Abstract

5-Hydroxytryptamine (5-HT) stimulated an increase in short-circuit current (ISC) in guinea-pig isolated ileal mucosa over a wide concentration range (0.1 nM-0.1 mM). The concentration-response relationship was biphasic, consisting of a high potency phase (0.1 nM-1 microM) and a low potency phase (3-10 microM). Stimulation of ISC observed at the high potency phase tended to be sustained while responses at the low potency phase (3-10 microM) contained two components, an initial "transient" response followed by a "maintained" response. Both the high potency phase (maximum stimulation approximately 30 microA cm-2) and the low potency phase (maximum stimulation approximately 80 microA cm-2) 5-HT response were antagonized by tetrodotoxin (TTX, 0.3 microM) and atropine (1 microM). However, another low potency (3 microM-0.1 mM, maximum stimulation approximately 30 microA cm-2) component of the 5-HT response was revealed in the presence of TTX or atropine. In the presence of methysergide (1 microM), the concentration-response relationship of 5-HT was still biphasic and tropisetron (0.1 and 10 microM) antagonized both phases of the 5-HT response. In the presence of methysergide, the high potency phase 5-HT response was mimicked by 5-methoxytryptamine (5-MeOT) and the selective 5-HT4 agonist SC-53116 but not by BIMU 8. The potent 5-HT4 antagonist GR 113808 antagonized the response to 5-MeOT in a surmountable manner with an affinity estimate of 9.6 +/- 0.3 (n = 4).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7675117     DOI: 10.1007/BF00170158

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  31 in total

1.  Pharmacology of indole-alkylamines.

Authors:  V ERSPAMER
Journal:  Pharmacol Rev       Date:  1954-12       Impact factor: 25.468

2.  Evidence for two types of 5-hydroxytryptamine receptor on secretomotor neurons of the guinea-pig ileum.

Authors:  R Hendriks; J C Bornstein; J B Furness
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-04       Impact factor: 3.000

3.  5-Methoxytryptamine and 2-methyl-5-hydroxytryptamine-induced desensitization as a discriminative tool for the 5-HT3 and putative 5-HT4 receptors in guinea pig ileum.

Authors:  D A Craig; R M Eglen; L K Walsh; L A Perkins; R L Whiting; D E Clarke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-07       Impact factor: 3.000

4.  Evidence for the involvement of a 5-HT4 receptor in the secretory response of human small intestine to 5-HT.

Authors:  R A Borman; D E Burleigh
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

5.  Evidence for the involvement of 5-hydroxytryptamine 4 receptors in 5-hydroxytryptophan-induced diarrhea in mice.

Authors:  S S Hedge; T M Moy; M R Perry; M Loeb; R M Eglen
Journal:  J Pharmacol Exp Ther       Date:  1994-11       Impact factor: 4.030

6.  Short-circuit current responses to 5-hydroxytryptamine in human ileal mucosa are mediated by a 5-HT4 receptor.

Authors:  D E Burleigh; R A Borman
Journal:  Eur J Pharmacol       Date:  1993-09-07       Impact factor: 4.432

7.  Azabicycloalkyl benzimidazolone derivatives as a novel class of potent agonists at the 5-HT4 receptor positively coupled to adenylate cyclase in brain.

Authors:  A Dumuis; M Sebben; E Monferini; M Nicola; M Turconi; H Ladinsky; J Bockaert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-03       Impact factor: 3.000

8.  Selective 5-hydroxytryptamine type 3 receptor antagonism with ondansetron as treatment for diarrhea-predominant irritable bowel syndrome: a pilot study.

Authors:  C J Steadman; N J Talley; S F Phillips; A R Zinsmeister
Journal:  Mayo Clin Proc       Date:  1992-08       Impact factor: 7.616

9.  Effect of a 5HT3-antagonist (ondansetron) on rectal sensitivity and compliance in health and the irritable bowel syndrome.

Authors:  J Hammer; S F Phillips; N J Talley; M Camilleri
Journal:  Aliment Pharmacol Ther       Date:  1993-10       Impact factor: 8.171

10.  Neurons with 5-hydroxytryptamine-like immunoreactivity in the enteric nervous system: their visualization and reactions to drug treatment.

Authors:  M Costa; J B Furness; A C Cuello; A A Verhofstad; H W Steinbusch; R P Elde
Journal:  Neuroscience       Date:  1982-02       Impact factor: 3.590

View more
  3 in total

1.  An improved in vitro bioassay for the study of 5-HT(4) receptors in the human isolated large intestinal circular muscle.

Authors:  N H Prins; N P Shankley; N J Welsh; M R Briejer; R A Lefebvre; L M Akkermans; J A Schuurkes
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

2.  Further investigation into the signal transduction mechanism of the 5-HT4-like receptor in the circular smooth muscle of human colon.

Authors:  P G McLean; I M Coupar
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

3.  Investigation of the 5-hydroxytryptamine receptor mediating the "transient" short-circuit current response in guinea-pig ileal mucosa.

Authors:  E Leung; D Blissard; M F Jett; R M Eglen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-06       Impact factor: 3.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.